Effective Use Of Oral Ribavirin For Respiratory Syncytial Viral Infections In Adult Allogeneic Haematopoietic Stem Cell Transplant Recipients

To our knowledge, this is the largest single centre study yet performed on adult allogeneic HSCT recipients with RSV infection treated with oral ribavirin. Prompt initiation of treatment is essential and may avoid hospital admission. Our experience supports the use of oral ribavirin, but large prospective studies are needed to determine the optimal therapy in this patient group.